ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,114.77
0.29%
US Tech 100
17,300.40
0.35%
다우존스 지수
38,309.52
0.18%
Bitcoin
62,793.19
-0.33%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Revance Therapeutics Inc (RVNC)

  7. Revance Therapeutics Inc (RVNC) 뉴스

RVNC Revance Therapeutics Inc

3.655
0.255 (7.50%)
최종 업데이트: 23:28:38
15분 지연
기업명 주식 심볼 시장 주식 타입
Revance Therapeutics Inc RVNC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.255 7.50% 3.655 23:28:38
개장가 저가 고가 종가 전일 종가
3.45 3.41 3.6799 3.40
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/04/202421:00BWRevance to Present New DAXXIFY® Data at the American Academy..
28/03/202405:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
09/03/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:08EDGAR2Form 8-K - Current report
06/03/202407:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/03/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202423:25BWRevance Announces Pricing of $100.0 Million Public Offering..
04/03/202420:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/03/202420:37BWRevance Announces Proposed Public Offering of Common Stock
01/03/202406:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/02/202406:07EDGAR2Form 8-K - Current report
29/02/202406:05BWRevance Reports Fourth Quarter and Full Year 2023 Financial..
21/02/202422:01BWRevance to Release Fourth Quarter and Full Year 2023..
21/02/202422:00BWRevance to Participate in Upcoming Investor Conferences
15/02/202405:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:28EDGAR2Form 8-K - Current report
13/02/202423:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/02/202406:04EDGAR2Form 8-K - Current report
03/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202422:00BWRevance Receives Permanent J-Code for DAXXIFY® and Announces..
01/02/202422:00BWRevance to Participate in the Guggenheim 6th Annual..
11/01/202420:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
08/01/202422:01EDGAR2Form 8-K - Current report
08/01/202422:00BWRevance Provides Corporate Update, Preliminary Fourth..
04/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202306:04EDGAR2Form 8-K - Current report
12/12/202319:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
15/11/202306:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202306:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:09EDGAR2Form 8-K - Current report
09/11/202306:06BWRevance Reports Third Quarter 2023 Financial Results,..
09/11/202306:05BWRevance Appoints Erica Jordan as Chief Commercial Officer,..
06/11/202322:00BWRevance to Participate in Upcoming Investor Conferences
01/11/202321:00BWRevance to Release Third Quarter 2023 Financial Results on..
26/10/202321:00BWDAXXIFY® Becomes First Facial Injectable to be Named to..
25/10/202305:05EDGAR2Form SC 13D/A - General statement of acquisition of..
19/09/202322:01EDGAR2Form 8-K - Current report
19/09/202322:00BWRevance Provides Corporate Update at Investor Day
08/09/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202305:21EDGAR2Form 144 - Report of proposed sale of securities
06/09/202306:43EDGAR2Form 144 - Report of proposed sale of securities
01/09/202322:12EDGAR2Form SC 13D - General statement of acquisition of beneficial..

최근 히스토리

NASDAQ
RVNC
Revance Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유